Uploaded July 2026 | Updated November 2026, 3 hours ago
Some of the most devastating neurological diseases begin with a small
error that grows. A short DNA sequence, repeated a few times in a healthy
gene, expands until it becomes something the cell can no longer handle.
This animation looks at repeat expansion diseases such as ALS and
frontotemporal dementia linked to the C9ORF72 gene, and at the antisense
therapies being developed to counter them.
Once the expanded gene is transcribed, it produces RNA molecules carrying
the repetitive sequence. These RNAs cluster into structures called RNA
foci, and some are translated into toxic dipeptide repeat proteins, or
DPRs.
Antisense oligonucleotides, or ASOs, are short modified DNA molecules
designed to recognize a specific RNA sequence. When an ASO binds its
target, the resulting hybrid is recognized by the enzyme RNase H, which
degrades the harmful RNA and leaves the ASO free to act again.
By lowering the levels of these repetitive RNAs, the aim is to limit their
damaging effects inside the cell.
#ALS #FrontotemporalDementia #C9ORF72 #AntisenseTherapy #Neurodegeneration
#MolecularBiology #ScientificAnimation
Some of the most devastating neurological diseases begin with a small
error that grows. A short DNA sequence, repeated a few times in a healthy
gene, expands until it becomes something the cell can no longer handle.
This animation looks at repeat expansion diseases such as ALS and
frontotemporal dementia linked to the C9ORF72 gene, and at the antisense
therapies being developed to counter them.
Once the expanded gene is transcribed, it produces RNA molecules carrying
the repetitive sequence. These RNAs cluster into structures called RNA
foci, and some are translated into toxic dipeptide repeat proteins, or
DPRs.
Antisense oligonucleotides, or ASOs, are short modified DNA molecules
designed to recognize a specific RNA sequence. When an ASO binds its
target, the resulting hybrid is recognized by the enzyme RNase H, which
degrades the harmful RNA and leaves the ASO free to act again.
By lowering the levels of these repetitive RNAs, the aim is to limit their
damaging effects inside the cell.
#ALS #FrontotemporalDementia #C9ORF72 #AntisenseTherapy #Neurodegeneration
#MolecularBiology #ScientificAnimation










